A largely unknown influenza virus, designated influenza D, is circulating among cattle populations globally, raising concerns among scientists about its potential to jump to humans and trigger a new pandemic. Although influenza A and B viruses are responsible for seasonal flu in people, influenza D has historically been considered a less significant threat, primarily affecting livestock. However, recent observations of increased illness in cattle, coupled with a growing understanding of the virus’s characteristics, are prompting a reassessment of its risk profile. The emergence of this virus underscores the constant threat of zoonotic diseases – those that can transmit from animals to humans – and the need for robust surveillance systems.
The initial focus on influenza D began with observations of respiratory illness in cattle, particularly in Asia and Europe. Researchers, including a team at the University of Texas, Galveston, have been working to understand the virus’s spread and potential for mutation. Influenza D is one of four known types of influenza viruses; influenza A is the most well-known and causes annual epidemics that kill tens of thousands worldwide. The current situation with influenza D is particularly concerning because of its ability to infect and spread within cattle populations, creating a potential reservoir for the virus to evolve and adapt.
What is Influenza D and Why is it Concerning?
Influenza D virus was first identified in 2007, and primarily infects pigs. However, recent research, as detailed in a January 2026 publication in the journal Emerging Infectious Diseases, shows it is now widespread in cattle. The virus is genetically distinct from influenza A and B, and while it doesn’t appear to cause severe illness in cattle, its presence in a large animal population raises the possibility of antigenic shift – a process where the virus undergoes significant genetic changes, potentially allowing it to infect humans more easily. Gregory C. Gray, Anastasia N. Vlasova, John A. Lednicky, Thang Nguyen-Tien, Ismaila Shittu, and Feng Li, authors of the Emerging Infectious Diseases article, emphasize that diagnostics and surveillance for influenza D are currently lacking, hindering efforts to track its spread and assess the risk to human health.
The concern isn’t simply that influenza D could cause illness directly. A significant worry is the potential for the virus to reassort with existing influenza A viruses in humans, creating a novel strain with unpredictable characteristics. This process, known as reassortment, is how many past pandemic influenza strains have emerged. The Centers for Disease Control and Prevention (CDC) is actively monitoring the situation, but as of January 21, 2026, no human or veterinary laboratory-approved tests are available to detect the virus.
The Role of Canine Coronavirus HuPn-2018
Alongside influenza D, scientists are too keeping a close watch on canine coronavirus HuPn-2018. The University of Florida Health reports that both viruses are considered potential emerging public health threats. HuPn-2018, first identified in 2018, has shown the ability to cause respiratory illness in dogs and, importantly, has demonstrated the potential to infect human cells in laboratory settings. While human infections remain rare, the virus’s ability to cross the species barrier is a cause for concern.
Current Situation and Global Spread
The spread of influenza D among cattle has been documented in multiple countries, including those in Asia, Europe, and North America. The exact mechanisms of transmission are still under investigation, but it’s believed to spread through close contact between animals, potentially via respiratory droplets or contaminated surfaces. The economic impact on the cattle industry is also a growing concern, as outbreaks can lead to reduced productivity and trade restrictions. The situation is evolving rapidly, and ongoing surveillance is crucial to understanding the full extent of the outbreak.
The lack of widespread testing for influenza D makes it difficult to determine the true prevalence of the virus in cattle populations. Current diagnostic efforts are largely focused on identifying the virus in symptomatic animals, but it’s likely that many infected animals remain undetected. This underscores the need for increased investment in diagnostic tools and surveillance programs.
What Can Be Done?
Public health officials emphasize the importance of several key measures to mitigate the risk posed by influenza D and HuPn-2018. These include:
- Enhanced Surveillance: Expanding surveillance programs in both animal and human populations to track the spread of the viruses and detect potential outbreaks early.
- Diagnostic Development: Investing in the development of rapid and accurate diagnostic tests for both influenza D and HuPn-2018.
- Vaccine Research: Initiating research to develop vaccines that can protect both animals and humans from infection.
- Biosecurity Measures: Implementing strict biosecurity measures on farms and in veterinary facilities to prevent the spread of the viruses.
- Public Awareness: Educating the public about the risks posed by these viruses and the importance of practicing great hygiene.
As we prepare for the next pandemic, experts suggest heeding the lessons learned from previous outbreaks. The rapid emergence and spread of novel viruses like influenza D and HuPn-2018 highlight the interconnectedness of human, animal, and environmental health. A One Health approach – which recognizes the interdependence of these factors – is essential for preventing and responding to future pandemics.
The next official update on influenza D surveillance and research is expected from the CDC in late March 2026. Continued monitoring of the virus’s evolution and spread will be critical in assessing the ongoing risk to human health.
This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Share this article with your network to raise awareness about this emerging health threat. Your comments and questions are welcome below.
